236 related articles for article (PubMed ID: 19266358)
1. Abnormal cervical cytology is associated with increased nitric oxide release in the uterine cervix.
Rahkola P; Mikkola TS; Nieminen P; Ylikorkala O; Vaisanen-Tommiska M
Acta Obstet Gynecol Scand; 2009; 88(4):417-21. PubMed ID: 19266358
[TBL] [Abstract][Full Text] [Related]
2. Cervical nitric oxide release in Chlamydia trachomatis and high-risk human papillomavirus infection.
Rahkola P; Väisänen-Tommiska M; Hiltunen-Back E; Auvinen E; Ylikorkala O; Mikkola TS
Acta Obstet Gynecol Scand; 2011 Sep; 90(9):961-5. PubMed ID: 21644935
[TBL] [Abstract][Full Text] [Related]
3. Misoprostol induces cervical nitric oxide release in pregnant, but not in nonpregnant, women.
Väisänen-Tommiska M; Mikkola TS; Ylikorkala O
Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 1):790-6. PubMed ID: 16150276
[TBL] [Abstract][Full Text] [Related]
4. Cervical nitric oxide release in women postterm.
Väisänen-Tommiska M; Nuutila M; Ylikorkala O
Obstet Gynecol; 2004 Apr; 103(4):657-62. PubMed ID: 15051555
[TBL] [Abstract][Full Text] [Related]
5. A spectral phenotype of oncogenic human papillomavirus-infected exfoliative cervical cytology distinguishes women based on age.
Kelly JG; Cheung KT; Martin C; O'Leary JJ; Prendiville W; Martin-Hirsch PL; Martin FL
Clin Chim Acta; 2010 Aug; 411(15-16):1027-33. PubMed ID: 20359472
[TBL] [Abstract][Full Text] [Related]
6. Changes in cervical nitric oxide concentration correlate with Bishop score and cervical length modifications in prostaglandin E2-mediated induction of labor.
Chiossi G; Verocchi G; Venturini P; Facchinetti F
J Soc Gynecol Investig; 2006 Apr; 13(3):203-8. PubMed ID: 16638591
[TBL] [Abstract][Full Text] [Related]
7. Determination of cervicovaginal microorganisms in women with abnormal cervical cytology: the role of Ureaplasma urealyticum.
Lukic A; Canzio C; Patella A; Giovagnoli M; Cipriani P; Frega A; Moscarini M
Anticancer Res; 2006; 26(6C):4843-9. PubMed ID: 17214350
[TBL] [Abstract][Full Text] [Related]
8. Smoking is accompanied by a suppressed cervical nitric oxide release in women with high-risk human papillomavirus infection.
Rahkola-Soisalo P; Mikkola TS; Vuorento S; Ylikorkala O; Väisänen-Tommiska M
Acta Obstet Gynecol Scand; 2013 Jun; 92(6):711-5. PubMed ID: 23451878
[TBL] [Abstract][Full Text] [Related]
9. Mifepristone-induced nitric oxide release and expression of nitric oxide synthases in the human cervix during early pregnancy.
Väisänen-Tommiska M; Butzow R; Ylikorkala O; Mikkola TS
Hum Reprod; 2006 Aug; 21(8):2180-4. PubMed ID: 16684839
[TBL] [Abstract][Full Text] [Related]
10. Association between high risk papillomavirus DNA and nitric oxide release in the human uterine cervix.
Rahkola P; Mikkola TS; Ylikorkala O; Vaisanen-Tommiska M
Gynecol Oncol; 2009 Aug; 114(2):323-6. PubMed ID: 19481240
[TBL] [Abstract][Full Text] [Related]
11. Factors affecting decidual IGFBP-1 levels in the vagina and cervix in the first and mid-second trimester of pregnancy.
Rahkonen L; Unkila-Kallio L; Rutanen EM; Paavonen J
BJOG; 2009 Jan; 116(1):45-54. PubMed ID: 19016684
[TBL] [Abstract][Full Text] [Related]
12. Clinical follow-up of women infected with human papillomavirus-16, either alone or with other human papillomavirus types: identification of different risk groups.
Cottier O; Sahli R; Mihaescu A; De Grandi P; Boulvain M; Gerber S
Am J Obstet Gynecol; 2009 Mar; 200(3):286.e1-6. PubMed ID: 19167699
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of DAPK gene methylation and HPV and EBV infection in cervical cells from patients with normal cytology and colposcopy.
Lattario F; Furtado YL; Silveira FA; do Val IC; Almeida G; da Costa Carvalho Mda G
Arch Gynecol Obstet; 2008 Jun; 277(6):505-9. PubMed ID: 18026971
[TBL] [Abstract][Full Text] [Related]
14. The utility of human papillomavirus testing in the management of atypical glandular cells on cytology.
Sharpless KE; O'Sullivan DM; Schnatz PF
J Low Genit Tract Dis; 2009 Apr; 13(2):72-8. PubMed ID: 19387126
[TBL] [Abstract][Full Text] [Related]
15. [Detection of multiple human papillomavirus infection in cervical specimens by flow fluorescent hybridization].
Chen QY; Bian ML; Zhang XY; Ou H; Ma L
Zhonghua Yi Xue Za Zhi; 2009 Apr; 89(13):901-5. PubMed ID: 19671291
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of high-risk human papillomavirus in an inner-city population with atypical squamous cells of undetermined significance.
Allen GL; Klobocista MM; Sugarman S; Gravel K; Feldman D; Schnatz PF
J Low Genit Tract Dis; 2009 Apr; 13(2):63-5. PubMed ID: 19387124
[TBL] [Abstract][Full Text] [Related]
17. Cervical nitric oxide release and persistence of high-risk human papillomavirus in women.
Rahkola P; Väisänen-Tommiska M; Tuomikoski P; Ylikorkala O; Mikkola TS
Int J Cancer; 2011 Jun; 128(12):2933-7. PubMed ID: 21064030
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide metabolites in cervical fluid during pregnancy: further evidence for the role of cervical nitric oxide in cervical ripening.
Väisänen-Tommiska M; Nuutila M; Aittomäki K; Hiilesmaa V; Ylikorkala O
Am J Obstet Gynecol; 2003 Mar; 188(3):779-85. PubMed ID: 12634657
[TBL] [Abstract][Full Text] [Related]
19. Expression of HPV L1 capsid protein in cervical specimens with HPV infection.
Lee H; Lee KJ; Jung CK; Hong JH; Lee YS; Choi YJ; Lee KY; Park G
Diagn Cytopathol; 2008 Dec; 36(12):864-7. PubMed ID: 18855883
[TBL] [Abstract][Full Text] [Related]
20. Proliferation patterns of cervical cells as visualized in Leiden liquid cytology slides.
Luzzatto L; van Haaften C; Boon ME
Diagn Cytopathol; 2004 Jul; 31(1):5-9. PubMed ID: 15236256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
